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Abstract
Objective: The main objective of this systematic literature review is to identify the safest and most effective seda-
tive drugs so as to ensure successful sedation with as few complications as possible.
Study Design: A systematic literature review of the PubMed MEDLINE database was carried out using the key 
words “conscious sedation,” “drugs,” and “dentistry.” A total of 1,827 scientific articles were found, and these 
were narrowed down to 473 articles after applying inclusion and exclusion criteria. These 473 studies were then 
individually assessed for their suitability for inclusion in this literature review.
Results: A total of 21 studies were selected due to their rigorous study design and conduciveness to further, more 
exhaustive analysis. The selected studies included a total of 1,0003 patients classified as ASA I or II. Midazolam 
was the drug most frequently used for successful sedation in dental surgical procedures. Ketamine also proved 
very useful when administered intranasally, although some side effects were observed when delivered via other 
routes of administration. Both propofol and nitrous oxide (N2O) are also effective sedative drugs.
Conclusions: Midazolam is the drug most commonly used to induce moderate sedation in dental surgical proce-
dures, and it is also very safe. Other sedative drugs like ketamine, dexmedetomidine and propofol have also been 
proven safe and effective; however, further comparative clinical studies are needed to better demonstrate which of 
these are the safest and most effective.
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Introduction
Conscious sedation is an effective method of reducing 
preoperative anxiety in children and in adult patients 
who suffer from anxiety, especially prior to surgical 
procedures requiring general anesthesia. When admin-
istered before dental treatments, conscious sedation 
methods have been shown to aid in the reduction of pa-
tient pain and anxiety. Conscious sedation is very use-
ful in encouraging patient cooperation and improving 
overall patient satisfaction with dental treatment. How-
ever, conscious sedation methods do involve some level 
of risk for patients and dental practitioners (1). It is well 
known that conscious sedation allows dental practitio-
ners to treat uncooperative patients (2).
Some patients simply cannot be treated with locoregion-
al anesthesia alone for various reasons, generally due to 
behavioral problems resulting from some form of dis-
ability or because the patient is a child. In these cases, 
procedures must be performed with the patient under 
conscious sedation (3). However, in some cases requir-
ing very complex dental procedures, or if the patient is 
in poor condition, conscious sedation may be inadvis-
able or the class of drugs used may be contraindicated. 
The adverse effects associated with conscious sedation 
are a result of the class of drugs used, with hallucina-
tions being the most frequently observed adverse reac-
tion (4,5) linked to the use of benzodiazepines, propofol 
and nitrous oxide. Nitrous oxide may also cause damage 
to immune and hematologic systems, and it can cause 
fertility problems in women (6-9). However, the biggest 
disadvantage of conscious sedation is that it can mask 
symptoms of a medical emergency, so clinicians should 
remain very conscious of proper methods of sedation 
for dental procedures and their importance (10).
Clinics that employ methods of conscious sedation are 
required to have the equipment necessary to handle 
medical emergencies such as hypoventilation or central 
nervous system depression (11-13). The most important 
consideration when dealing with a potential emergency 
is to have a highly qualified team capable of handling 
any issues that may arise, especially any respiratory 
complications.
Today, there are a wide variety of drugs that can be used 
to sedate patients (14); however, there are relatively few 
studies that compare the safety and effectiveness of dif-
ferent kinds of sedatives. Therefore, the main objective 
of this systematic literature review is to identify the saf-
est and most effective sedative drugs so as to ensure 
successful sedation with as few complications as pos-
sible.
Material and Methods
To fulfill the given objectives, a systematic literature 
review was undertaken using the PubMed MEDLINE 
database, with a view to identifying the safest and most 
effective sedative drug in order to provide dental prac-
titioners with updated information on whichever drugs 
were found to be the most suitable. A total of 4,740 sci-
entific articles were found by entering the key words 
“drugs” and “sedation” into the PubMed MEDLINE da-
tabase. The search was then further limited to clinical 
trials, which narrowed the results down to 473 studies.
These 473 results were then individually assessed for 
their suitability for inclusion in this literature review, 
with a total of 21 studies being selected due to their rig-
orous study design and conduciveness to further, more 
exhaustive analysis; in this case, only prospective ran-
domized studies were classified as rigorous.
The only studies selected were prospective randomized 
studies; any studies that were not prospective were dis-
carded. Other inclusion criteria stipulated that studies 
focus on sedative drugs administered to either healthy 
patients or patients with specialized treatment needs, 
including need for buccal or cervicofacial surgical in-
tervention, or studies that compared and assessed dif-
ferent drugs used to induce light or moderate sedation. 
See figure 1 for a diagram detailing how this literature 
review was carried out. 
Results
The selected articles studied a total of 1,003 patients 
classified as ASA I or II. 
Table 1 and 1 continue provides an overview of each of the 
selected articles: Authors, year of publication, number of 
patients treated, drugs administered, route(s) of adminis-
tration, medical specialty, and conclusions reached.
Upon analyzing the different kinds of sedative drugs 
used, it appears midazolam was used 24 times in 15 stud-
ies, in varying concentrations (0.005 mg/kg, 0.06 mg/kg, 
0.2 mg/kg, 0.3 mg/kg, and 0.5 mg/kg). It was adminis-
tered orally in 10 studies, intranasally in 5, intravenously 
in another 5 studies, and in one study it was administered 
via an aerosolized buccal spray. On one occasion, it was 
administered using a transmucosal syrup, through intra-
muscular injection, and submucosally. All of the studies 
showed that midazolam can be used safely and effective-
ly to induce light or moderate sedation.
Ketamine was administered 12 times in varying con-
centrations (0.25 mg/kg, 5 mg/kg, 6 mg/kg, 10 mg/
kg, and 50 mg/kg) over 9 different studies. It was ad-
ministered intranasally in 4 studies, intravenously in 2 
studies, orally in 5 studies (in one case, the patient was 
given a ketamine-laced lollipop), and via intramuscular 
injection in one study. The drug proved to be a highly 
effective sedative in all of these studies.
Two different studies administered dexmedetomidine 
intravenously and intranasally in two different con-
centrations (1 µg/kg and 1.5 µg/kg), and the drug was 
shown to be a viable alternative to midazolam. 
Clonidine was tested in two studies using varying con-
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centrations (2 µg/kg, 4 µg/kg, 3-4 µg/kg, and 7-8 µg/
kg). It was administered intranasally twice and orally 
on one occasion.
Two studies administered atropine intranasally, orally, or 
intramuscularly in varying concentrations (0.02 mg/kg, 
0.05 mg/kg, and 20 mg/kg). Atropine helps to reduce the 
increased salivation often caused by ketamine, and it also 
helps facilitate the absorption of clonidine.
Between 1-1.5 mg/kg of propofol were administered 
intravenously in 2 different articles. Propofol is a safe 
method of sedation, but it is less potent than intravenous 
ketamine.
Three articles assessed the use of diazepam in concentra-
tions of 0.5 mg/kg and 5 mg/kg. It was always adminis-
tered orally, and it proved less effective than midazolam.
Chloral hydrate was administered orally in 2 articles, in 
concentrations of 40 mg/kg, 50 mg/kg, and 75 mg/kg. 
The drug provided good results.
The following drugs were used in only one study: 0.5 
mg/kg of alprazolam, administered orally; 3 mg of me-
latonin, also administered orally; 1-1.5 mg/kg of keto-
fol, administered intravenously; 70 mg/kg of triclofos, 
administered orally; 0.3 µg/k of fentanyl via submu-
cosal administration; and 2 mg/kg of hydroxyzine. A 
placebo was administered on six occasions.
 
Discussion
There are a wide range of drugs, routes of administra-
tion, and varying clinical protocols that can be used to 
induce conscious or deep sedation.
Fig. 1. Literature Review Diagram.
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AUTHORS DATE TYPE OF 
STUDY 
Nº of 
PATIENTS 
DRUGS USED AND 
DOSAGE 
ROUTE OF 
ADMINISTRATION 
 
SPECIALTY CONCLUSIONS 
Surendar,  
et al. (15) 
2014 Randomized 
Triple-blind 
84 
 
Dexmedetomidine 1 
!g/kg 
Dexmedetomidine 1.5 
!g /kg  
Midazolam  
0.2 mg/kg 
Ketamine 5 mg/kg 
Intranasal 
 
 
Dentistry All the drugs are 
safe and effective 
in the light 
sedation of 
uncooperative 
patients 
Pokharel, 
et al. (16) 
2014 Prospective 
Double-
blind 
Randomized 
80 
 
Alprazolam 0.5 mg + 
melatonin 3 mg 
Alprazolam 0.5 mg 
Melatonin 3 mg 
Placebo 
Oral 
 
 
 
 
Anesthesiology The combination 
of alprazolam 
with melatonin 
reduces anxiety 
Level of sedation 
is similar to the 
alprazolam groups 
Mitra,  
et al. (17) 
2014 Prospective 
Double-
blind 
Randomized 
60 
 
Clonidine 4 !g/kg + 
Atropine 20 !g/kg 
Midazolam 0.3 mg/kg 
Intranasal 
 
 
Intravenous 
 
Anesthesiology Midazolam 
provides a faster-
onset sedation; 
both drugs 
provide adequate 
anxiolysis after 30 
minutes 
Mittal,  
et al. (34) 
2013 Prospective 
Double-
blind 
Randomized 
40 
 
Propofol 1-1.5 mg/kg 
Ketofol 1-1.5 mg/kg + 
Ketamine 0.25 mg/kg 
Intravenous 
 
Dentistry Propofol is safer 
but both drugs 
have similar 
sedative effects 
Tyagi,  
et al. (18) 
2013 Prospective 
Randomized 
Triple-blind 
40 
 
Midazolam 0.5mg/kg 
Diazepam 0.5 mg/kg 
Midazolam 0.06 
mg/kg 
Placebo 
Oral 
Oral 
Intravenous 
Oral 
Dentistry Midazolam allows 
for a higher level 
of sedation, better 
anxiolysis, and it 
is safer than 
diazepam 
Chopra,  
et al. (19) 
2013 Prospective 
Randomized 
 
30 
 
Midazolam  
 
Midazolam  
Aerosol mouth spray 
Intranasal 
 
Dentistry Oral midazolam is 
more effective but 
not significantly 
so 
Fan, 
et al. (20) 
2013 Prospective 
Double-
blind 
Randomized 
60 
 
Midazolam 0.005 
mg/kg/min 
Dexmedetomidine 0.1 
!g/kg/min 
Intravenous 
Intravenous 
Dentistry Dexmedetomidine 
is a good 
alternative to 
midazolam for 
achieving 
adequate levels of 
sedation 
Tyagi,  
et al. (21) 
2012 Prospective 
Randomized 
Triple-blind 
40 
 
Midazolam 0.5 mg/kg 
Diazepam 0.5 mg/kg 
Midazolam 0.06 
mg/kg 
Placebo 
Oral 
Oral 
Intravenous 
Oral 
Dentistry Midazolam has 
stronger sedative 
effects than 
diazepam 
Horacek,  
et al. (22) 
2012 Prospective 
Double-
blind 
Randomized 
29 
 
Ketamine 5 mg/kg + 
Clonidine 2 !g/kg + 
Midazolam 0.3 mg/kg 
Ketamine 5 mg/kg + 
Midazolam 0.3 mg/kg  
Oral 
Oral 
 
Dentistry Oral ketamine and 
midazolam are 
safe and effective 
sedatives 
 
 
Pandey,  
et al. (33) 
2011 Prospective 
Randomized 
 
34 
 
Ketamine 
Ketamine 
Intranasal spray 
Intranasal drops 
Dentistry The spray is better 
tolerated than the 
intranasal drops, 
but both are 
equally effective 
Larsson,  
et al. (35) 
 
 
 
2012 Prospective 
Double-
blind 
Randomized 
60 
 
 
Saline placebo  
Clonidine 3-4 !g/kg 
Clonidine 7-8 !g/kg 
Intranasal 
Intranasal 
Anesthesiology Clonidine 
provides adequate 
sedation in both 
groups 
Table 1. Authors, year of publication, number of patients, drugs administered, route of administration, medical specialty, and conclusions 
of each of the analyzed articles.
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Table 1 continue. Authors, year of publication, number of patients, drugs administered, route of administration, medical specialty, and 
conclusions of each of the analyzed articles.
 
Bahetwar,  
et al. (23) 
 
2011 
 
Prospective 
Randomized 
 
45 
 
 
 
Midazolam 
Ketamine 
Midazolam + 
Ketamine 
 
Intranasal 
Intranasal 
Intranasal 
 
Dentistry 
 
Both drugs induce 
moderate 
sedation, but 
ketamine is more 
effective 
Klein,  
et al. (24) 
2011 Prospective 
Randomized 
169 
 
Midazolam 
Midazolam 
Midazolam 
Intranasal 
Aerosol mouth spray 
Oral 
 
Facial and 
orofacial 
surgery 
Midazolam mouth 
spray is the most 
effective route of 
administration 
Shabbir,  
et al. (25) 
2011 Prospective 
Randomized 
12 
 
Triclofos 70 mg/kg 
Midazolam 0.5mg/kg 
Oral 
Oral 
Dentistry Oral midazolam is 
more effective 
than triclofos 
 
Pandey, (26) 2010 Prospective 
Randomized 
Triple-blind 
23 
 
Fentanyl 0.3 !g/kg  
+ Midazolam 0.5 
mg/kg 
Placebo + Midazolam 
0.5 mg/kg 
Submucosal 
Oral 
Dentistry A combination of 
fentanyl and 
midalozam 
improves sedative 
effects  
 
Dangerous 
(oxygen 
desaturation), a 
combination of 
fentanyl and 
midazolam 
improves sedative 
effects but may 
cause oxygen 
desaturation  
Damle,  
et al. (27) 
2008 Prospective 
Randomized 
Double-
blind 
20 
 
Midazolam 0.5 mg/kg 
Ketamine 5 mg/kg 
Oral 
Oral 
Dentistry After 30 minutes, 
midazolam shows 
greater sedative 
effects with less 
side effects 
Da Costa, (28) 2007 Prospective 
Randomized 
Double-
blind 
12 
 
Placebo 
Chloral hydrate 75 
mg/kg 
Chloral hydrate 50 
mg/kg + Hydroxyzine 
2 mg/kg 
Oral 
Oral 
Oral 
Dentistry Chloral hydrate is 
a viable method 
of sedation, 
however 
hydroxyzine does 
not lend any 
additional benefits 
Rai, 
et al. (32) 
2007 Prospective 
Randomized 
30 
 
Propofol 
Midazolam  
Ketamine 
Intravenous 
Intravenous 
Intravenous 
Dentistry Ketamine proved 
to be the most 
effective drug 
Bhatnagar,  
et al. (29) 
2008 Prospective 
Randomized 
60 
 
Ketamine 6 mg/kg 
+ Midazolam 0.05 
mg/kg + Atropine 
0.02 mg/kg 
Ketamine 10 mg/kg + 
Midazolam 0.2 mg/kg 
+ Atropine 0.05 
mg/kg 
Intramuscular 
Oral 
Oncology Both routes of 
administration are 
effective 
Oral 
administration is 
less painful 
Kantovitz,  
et al. (30) 
 
2007 Prospective 
Randomized 
Double-
blind 
20 
 
Chloral hydrate 40 
mg/kg 
Diazepam 5mg 
 
Oral 
Oral 
Dentistry Diazepam and 
chloral hydrate do 
not affect 
children’s 
behavior 
Horiuchi,  
et al. (31) 
2005 Prospective 
Randomized 
55 
 
Lollipop with 
ketamine 50 mg 
Midazolam oral syrup 
0.5 mg/kg 
Oral submucosal 
Oral 
Anesthesiology Ketamine 
administered 
transmucosally in 
the oral cavity 
does not appear to 
have any 
advantages over 
oral midazolam 
!
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Benzodiazepines are the class of drugs most often used 
to induce a state of anxiolysis, sedation, or amnesia (15). 
Of the articles selected for this review, midazolam is the 
most frequently used benzodiazepine (16-18-22,23-29).
Midazolam can be used to induce a safe and effective 
state of sedation without risk of cardiopulmonary com-
plications. This conclusion has been reached after com-
paring midazolam with other sedative drugs such as 
diazepam, ketamine, clonidine, and dexmedetomidine 
in double- and triple-blind randomized studies. In these 
studies, midazolam provided the best results in terms of 
onset time of action, depth of sedation, and anxiolysis 
(16-20,27).
Midazolam can be delivered in various ways, including 
via intravenous, intramuscular, submucosal, oral, or in-
tranasal routes of administration. The most commonly 
used routes of administration of midazolam are intrana-
sal, oral, or intravenous. Any of these can induce a state 
of anxiolysis, but only intravenous administration of 
midazolam can induce a state of deep sedation, as dem-
onstrated by Tyagi et al. in a well-designed prospective 
randomized triple-blind study (18).
Oral and intramuscular routes of administration result 
in similar sedative effects, but the former is less invasive 
and better tolerated by patients, which lends it a signifi-
cant advantage (24,29). Intranasal administration of a 
midazolam spray is also an effective method of induc-
ing sedation and fast-onset anxiolysis. A level of moder-
ate sedation can be achieved with this drug and route of 
administration after about 30 minutes (16,17). However, 
the spray may cause symptoms such as bitter taste or 
burning sensations or pain within the nose. These side 
effects can be avoided by opting for a buccal midazolam 
spray applied to the oral mucosa, which is well tolerated 
by uncooperative patients (19,24). Although this method 
has been studied in various clinical trials, only Klein et 
al. (24) carried out a randomized study.
Midazolam has only been used to sedate children, but 
it should not be the first option as hypoventilation may 
occur, depending on dose and any paradoxical reactions 
(17,29). However, midazolam can be used in conjunc-
tion with other sedatives like ketamine or propofol to 
help decrease the overall dosage needed, which also aids 
in minimizing any adverse effects and may promote 
quicker recovery times and a faster onset of sedative 
action (29). While this was demonstrated by one of the 
clinical trials evaluated as part of this systematic litera-
ture review, there is a need for additional double-blind 
studies in order to obtain more concrete evidence.
Other diazepines such as diazepam or alprazolam 
have also been successfully used to sedate patients 
(15,18,21,30).
Diazepam and midazolam exhibit similar sedative ef-
fects, but the latter provides a better anxiolytic effect 
as well as a minimally higher level of sedation; there-
fore, diazepam does not offer any sedative advantage 
over midazolam (18,21). Alprazolam is a highly effec-
tive anxiolytic premedication, and when combined with 
melatonin it increases the latter’s sedative effects, thus 
inducing a deep level of sedation.
Ketamine is a dissociative anesthetic and analgesic that 
is also used as a sedative drug, maintaining the patient’s 
muscle tone and the respiratory system’s protective re-
flexes (29,31). However, in adults, ketamine may also 
cause hallucinations and nightmares during the recov-
ery period, and as such it sees limited use in adults; 
these side effects are rarely seen in children (31).
Intravenous ketamine has been shown to have a power-
ful sedative effect; some researchers actually preferred 
ketamine to midazolam due to increased patient coop-
erativeness and because it carried less side effects; more 
double- and triple-blind studies are necessary to compare 
its effectiveness with that of other drugs in order to ob-
tain sufficient scientific evidence for this claim (32).
On the other hand, when comparing oral midazolam and 
oral ketamine, while they exhibit similar sedative effects, 
midazolam is more conducive to anxiolysis, and orally 
administered ketamine results in a slower recovery pe-
riod post-sedation. These drugs were compared in a well-
designed, double-blind randomized clinical trial (27).
Ketamine can be delivered safely and effectively via an 
intranasal route of administration (16,26,29).
Transmucosal oral administration of ketamine has also 
been studied using a lollipop to deliver the drug, and 
its effectiveness was then compared with oral midazo-
lam without evidence of any greater sedative effects. 
However, only one of the studies reviewed examined 
this route of administration of ketamine, and while it 
was a randomized study, there is a need for additional, 
double-blind studies in order to obtain better evidence 
to this effect (31).
A combination of oral ketamine and oral midazolam 
results in safe and effective sedation (22,23,29), and a 
combination of oral ketamine, oral midazolam and atro-
pine significantly reduces the increased salivation often 
caused by ketamine (29). However, unfortunately these 
were not double-blind studies, which would have pro-
vided more concrete evidence.
Propofol is a short-acting intravenous sedative. This 
drug is very useful for surgical interventions in the oro-
facial area, which necessitate a higher quantity of local 
anesthesia with adrenaline; propofol can help balance 
cardiovascular alterations resulting from the adrenaline 
injection (32).
The sedative effects of propofol are stronger than those 
of midazolam, but it can also cause additional side effects 
such as sudden movements, crying fits, intermittent cough-
ing, and pain at the site of injection. Additionally, there is 
a risk of severe hypotension when administering propofol 
(33). However, while these studies were randomized, they 
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would benefit from larger sample sizes and a double-blind 
design in order to provide better evidence of this.
Propofol can also be combined with ketamine, although 
the combination of both these drugs may lead to hy-
poventilation. Therefore, as both drugs have similar 
sedative effects, it is safer to use propofol alone rather 
than combining the two sedatives. This is seen in Mittal 
et al.’s study; although a randomized double-blind clini-
cal trial, the study would have benefitted from a larger 
sample size (34). 
Clonidine and dexmedetomidine target the α-2 adrenergic 
receptor agonists, and their potential use as preoperative 
premedications has been studied extensively. 
Intranasal clonidine appears to induce an adequate level 
of sedation, working more slowly than midazolam but 
with fewer side effects, as demonstrated in a rigorous, ran-
domized double-blind study with a good sample size (17). 
Additionally, when combined with atropine, clonidine ap-
pears to be better absorbed and to have a more predictable 
effect on the reduction of nasal secretions (17).
Other studies found that clonidine did not have very 
strong sedative effects (35). Clonidine has also been 
studied in conjunction with ketamine and midazolam, 
without any additional benefits being found from using 
this combination (22).
Despite this, dexmedetomidine appears to function just 
as well as midazolam, providing a safe, moderate, and 
effective sedation. Additionally, some studies suggest it 
may even increase patient cooperation (16,20).
Chloral hydrate is another safe and effective sedative 
drug, but it does not appear to have any advantages over 
midazolam (28,30). A combination of chloral hydrate 
and hydroxyzine only results in more side effects, and 
therefore this combination should not be administered to 
patients (28). Triclofos was shown to have a less power-
ful sedative effect than midazolam (25). A combination 
of midazolam with submucosally administered opioids 
such as fentanyl results in a greater sedative effect, but 
this may also cause oxygen desaturation (26).
In conclusion, Midazolam is the most commonly used 
sedative drug in dental procedures (light sedation). It is 
a very safe sedative, and it is most often administered 
either intranasally or orally.
Ketamine also proves very useful when administered 
intranasally, inducing a high level of sedation (deeper 
than that of midazolam); however, when delivered via 
other routes of administration, various side effects have 
been observed. Intravenous propofol is also a very safe 
and effective sedative.
Other drugs like clonidine and dexmedetomidine have 
also been proven effective in inducing a state of con-
scious sedation.
However, further clinical trials are needed to compare 
these drugs and obtain more evidence in order to deter-
mine which of these are the safest and most effective.
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